PRIMIDONE Drug Patent Profile
✉ Email this page to a colleague
When do Primidone patents expire, and what generic alternatives are available?
Primidone is a drug marketed by Amneal Pharm, Anda Repository, Carnegie, Dr Reddys Labs Ltd, Hikma Intl Pharms, Impax Labs, Lannett, Oxford Pharms, Rubicon, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in PRIMIDONE is primidone. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the primidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Primidone
A generic version of PRIMIDONE was approved as primidone by WATSON LABS on December 31st, 1969.
Summary for PRIMIDONE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 11 |
Finished Product Suppliers / Packagers: | 19 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 24 |
Patent Applications: | 4,523 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PRIMIDONE |
Drug Sales Revenues: | Drug sales revenues for PRIMIDONE |
What excipients (inactive ingredients) are in PRIMIDONE? | PRIMIDONE excipients list |
DailyMed Link: | PRIMIDONE at DailyMed |
Recent Clinical Trials for PRIMIDONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. Jurjan Aman | Phase 2 |
Exvastat Ltd. | Phase 2 |
Simbec Orion | Phase 2 |
Pharmacology for PRIMIDONE
Drug Class | Anti-epileptic Agent |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for PRIMIDONE
Anatomical Therapeutic Chemical (ATC) Classes for PRIMIDONE
US Patents and Regulatory Information for PRIMIDONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharm | PRIMIDONE | primidone | TABLET;ORAL | 040866-001 | Apr 23, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Rubicon | PRIMIDONE | primidone | TABLET;ORAL | 214896-003 | Dec 28, 2022 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dr Reddys Labs Ltd | PRIMIDONE | primidone | TABLET;ORAL | 040862-001 | Oct 3, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Anda Repository | PRIMIDONE | primidone | TABLET;ORAL | 040626-002 | Sep 29, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Impax Labs | PRIMIDONE | primidone | TABLET;ORAL | 040717-002 | Feb 12, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | PRIMIDONE | primidone | TABLET;ORAL | 083551-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |